| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |